Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A universal chemoenzymatic labeling system for profiling cell-cell interactions and potentiating targeted tumor immunotherapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Interleukin-27 remodels the bone marrow niche to suppress B-cell development and leukaemia progression in mouse models.

EBioMedicine·2026
Same author

Efficient Capture and Traceless Release of Functional CD8<sup>+</sup> T Cells with a Microfluidic Chip for Enhanced <i>In Vitro</i> and <i>In Viv</i><i>o</i> CD4-CAR Transduction.

Analytical chemistry·2024
Same author

Trafficking circuit of CD8<sup>+</sup> T cells between the intestine and bone marrow governs antitumour immunity.

Nature cell biology·2024
Same author

Interleukin-27 Promotes the Generation of Myeloid-derived Suppressor Cells to Alleviate Graft-versus-host Disease.

Transplantation·2024
Same author

Construction of a versatile fusion protein for targeted therapy and immunotherapy.

Protein science : a publication of the Protein Society·2024

Related Experiment Video

Updated: Jun 27, 2025

Conjugative Mating Assays for Sequence-specific Analysis of Transfer Proteins Involved in Bacterial Conjugation
10:41

Conjugative Mating Assays for Sequence-specific Analysis of Transfer Proteins Involved in Bacterial Conjugation

Published on: January 4, 2017

13.8K

Construction of Switch Modules for CAR-T Cell Treatment Using a Site-Specific Conjugation System.

Tuersunayi Abudureheman1, Hang Zhou1,2, Li-Ting Yang1

  • 1Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Bioconjugate Chemistry
|April 25, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel bispecific safety switch module for chimeric antigen receptor T-cell (CAR-T) therapy. This innovation enhances CAR-T cell efficacy against various tumors and improves treatment safety.

More Related Videos

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.5K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

195

Related Experiment Videos

Last Updated: Jun 27, 2025

Conjugative Mating Assays for Sequence-specific Analysis of Transfer Proteins Involved in Bacterial Conjugation
10:41

Conjugative Mating Assays for Sequence-specific Analysis of Transfer Proteins Involved in Bacterial Conjugation

Published on: January 4, 2017

13.8K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.5K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

195

Area of Science:

  • Immunotherapy
  • Oncology
  • Biotechnology

Background:

  • Chimeric antigen receptor T-cell (CAR-T) therapy shows promise for B-cell hematological tumors.
  • Limitations include limited target antigens and antigen loss leading to relapse.
  • Expanding CAR-T therapy requires novel strategies to broaden applicability and improve safety.

Purpose of the Study:

  • To develop a novel bispecific safety switch module for CAR-T cell therapy.
  • To enhance the targeting and cytotoxic capabilities of CAR-T cells against various tumor types.
  • To improve the safety and efficacy of CAR-T therapy through site-specific conjugation.

Main Methods:

  • Conjugation of an antibody (Ab) fusion protein with FITC-SpyTag (FITC-ST) peptide via site-specific conjugation.
  • Construction of FMC63 (anti-CD19), antiPDL1, and ZHER (anti-Her2)-FITC-ST switch modules.
  • Generation of anti-FITC CAR-T cells and anti-FITC CD8-CAR-T cells for targeting tumor cells.

Main Results:

  • The developed safety switch modules significantly enhanced the cytotoxic effects of anti-FITC CAR-T cells on CD19, PDL1, and Her2-expressing tumor cells.
  • Optimized CD8+ T cells generated anti-FITC CD8-CAR-T cells, which, with the CD4-FITC-ST module, eliminated CD4-positive tumor cells in vitro and in vivo.
  • The site-specific conjugation system successfully created a bispecific safety switch module.

Conclusions:

  • A novel safety switch module was successfully established using site-specific conjugation.
  • This module enhances the antitumor function of universal CAR-T cells.
  • The strategy expands the application scope of CAR-T therapy, improving its safety and efficacy.